Bath & Body Works (NYSE:BBWI) Issues FY 2026 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 2.400-2.650 for the period, compared to the consensus earnings per share estimate of 2.740. The company issued revenue guidance of -. Bath & Body Works also updated its Q1 2026 guidance to 0.240-0.300 EPS.

Bath & Body Works Price Performance

NYSE BBWI opened at $22.27 on Friday. Bath & Body Works has a one year low of $14.27 and a one year high of $35.21. The firm has a market cap of $4.56 billion, a P/E ratio of 7.07, a P/E/G ratio of 0.97 and a beta of 1.48. The stock’s 50-day moving average is $22.37 and its 200-day moving average is $23.58.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.28. The business had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.Bath & Body Works’s revenue for the quarter was down 2.3% compared to the same quarter last year. During the same period in the prior year, the business earned $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities analysts anticipate that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 6th. Investors of record on Friday, February 20th will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date is Friday, February 20th. Bath & Body Works’s dividend payout ratio (DPR) is presently 25.40%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. UBS Group upped their target price on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, February 23rd. Barclays boosted their price target on Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a report on Monday. Robert W. Baird set a $20.00 price objective on Bath & Body Works in a report on Wednesday, December 17th. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Finally, Wells Fargo & Company reduced their price target on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, November 21st. Three research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $24.00.

Key Headlines Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Q4 beat — BBWI reported Q4 EPS of $2.05 vs. $1.77 consensus and revenue of $2.72B vs. $2.59B, which pushed shares higher as investors rewarded the upside and management highlighted progress on its “Consumer First” strategy. Read More.
• Positive Sentiment: Analysts lift forecasts and price targets — multiple shops raised estimates and outlooks after the print; Telsey raised its price target to $25 (market perform), supporting near‑term upside. Read More.
• Neutral Sentiment: Research stance mixed — some firms (e.g., Barclays) kept non‑bullish/hold ratings despite the beat, indicating cautious sentiment among parts of the sell‑side. Read More.
• Neutral Sentiment: Minor price target tweaks — a few banks nudged targets modestly higher (Deutsche Bank/others), but changes are incremental relative to the stock’s volatility. Read More.
• Negative Sentiment: Weaker forward guidance — management set FY‑2026 EPS of $2.40–$2.65 (below the ~2.74 consensus) and Q1 EPS guidance of $0.24–$0.30 (well under street expectations), which undercuts the positive Q4 print and pressures forward valuation. Read More.
• Negative Sentiment: Soft sales outlook — the company warned of a steeper annual sales decline as customers pare back discretionary spending on premium scented products, signaling demand risks for the coming year. Read More.
• Negative Sentiment: Legal overhang — multiple law firms have filed or announced investigations into potential securities claims covering purchases between June 4, 2024 and Nov 19, 2025 and are soliciting lead plaintiffs ahead of deadlines in mid‑March; this increases uncertainty and could be a near‑term drag. Read More.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in BBWI. Royal Bank of Canada boosted its holdings in shares of Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after buying an additional 28,815 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in Bath & Body Works by 15.7% during the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock worth $19,586,000 after buying an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Bath & Body Works by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock worth $17,063,000 after acquiring an additional 36,684 shares in the last quarter. Intech Investment Management LLC acquired a new stake in Bath & Body Works in the first quarter valued at $1,155,000. Finally, Geneos Wealth Management Inc. lifted its stake in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.